(Q26851343)

B. Braam

2

1 reference

C. A. Gaillard

3

1 reference

M. J. Cramer

4

1 reference

R. Goldschmeding

5

1 reference

M. C. Verhaar

6

1 reference

P. A. Doevendans

7

1 reference

J. A. Joles

8

1 reference

language of work or name

1 reference

1 November 2012

1 reference

American Journal of Physiology - Renal Physiology

published in

1 reference

volume

303

1 reference

issue

9

1 reference

page(s)

F1253-63

1 reference

Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Cardiomyocyte loss in experimental renal failure: prevention by ramipril

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Imatinib ameliorates fibrosis in uraemic cardiac disease in BALB/c without improving cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Cardiorenal syndrome: new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Transient nitric oxide reduction induces permanent cardiac systolic dysfunction and worsens kidney damage in rats with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

The severe cardiorenal syndrome: 'Guyton revisited'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Cardiac structure and function in a mouse model of uraemia without hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Ischemic conditioning protects the uremic heart in a rodent model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Neural control of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Increased infarct size in uremic rats: reduced ischemia tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Renal denervation in moderate to severe CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Role of angiotensin II in the altered renal function of congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Nitric oxide modulates vascular disease in the remnant kidney model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Partial nephrectomy as a model for uremic cardiomyopathy in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Myocardial interstitial fibrosis in experimental uremia--implications for cardiac compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Intrarenal hemodynamics in low- and high-output cardiac failure in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Erythropoietin receptor signaling mitigates renal dysfunction-associated heart failure by mechanisms unrelated to relief of anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Low-dose growth hormone is cardioprotective in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Impairment of cardiac function and energetics in experimental renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Nitric oxide and cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Increased cardiovascular risk in rats with primary renal dysfunction; mediating role for vascular endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Pitavastatin inhibits cardiac hypertrophy in a rat model of progressive renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Myocardial infarction does not further impair renal damage in 5/6 nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Local modulation of the natriuretic peptide system in the rat remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Changes of vascular architecture independent of blood pressure in experimental uremia

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Effect of first myocardial ischemic event on renal function

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Renal venous congestion and renal function in congestive heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Myocardial hypertrophy in rats with renal insufficiency

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Reduced capillary density in the myocardium of uremic rats--a stereological study

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Diffuse intermyocardiocytic fibrosis in uraemic patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Endothelin-receptor antagonists in uremic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Subtotal nephrectomy plus coronary ligation leads to more pronounced damage in both organs than either nephrectomy or coronary ligation

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Low nitric oxide production in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Uremia aggravates left ventricular remodeling after myocardial infarction

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

The cardiorenal connection

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Cardiorenal and renocardiac syndromes: clinical disorders in search of a systematic definition

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Myocardial Morphology and Cardiac Function in Rats With Renal Failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Myocardial function, energy provision, and carnitine deficiency in experimental uremia

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system intervention

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00392.2012

7 January 2021

10.1152/AJPRENAL.00392.2012

Identifiers

DOI

0 references

Fatcat ID

release_gstvxgplkzgy3na3vbsxz5te2q

0 references

PubMed publication ID

22914779

1 reference